Alibaba Health Information Technology Management
Management Kriterienprüfungen 3/4
Alibaba Health Information Technology CEO ist Difan Shen , ernannt in Nov 2023, hat eine Amtszeit von 3.08 Jahren. Die jährliche Gesamtvergütung beträgt CN¥6.81M , bestehend aus 25.2% Gehalt und 74.8% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.009% der Aktien des Unternehmens, im Wert von HK$5.18M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.3 Jahre bzw. 2.3 Jahre.
Wichtige Informationen
Difan Shen
Geschäftsführender
CN¥6.8m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 25.2% |
| Amtszeit als Geschäftsführer | less than a year |
| Eigentum des Geschäftsführers | 0.009% |
| Durchschnittliche Amtszeit des Managements | 2.3yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 2.3yrs |
Jüngste Management Updates
Recent updates
Earnings Tell The Story For Alibaba Health Information Technology Limited (HKG:241) As Its Stock Soars 30%
Oct 18
What Does Alibaba Health Information Technology Limited's (HKG:241) Share Price Indicate?
Sep 23Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital
Jul 03After Leaping 26% Alibaba Health Information Technology Limited (HKG:241) Shares Are Not Flying Under The Radar
Jun 07Alibaba Health Information Technology's (HKG:241) Solid Earnings Are Supported By Other Strong Factors
Jun 06Risks Still Elevated At These Prices As Alibaba Health Information Technology Limited (HKG:241) Shares Dive 26%
Apr 21Is Now The Time To Look At Buying Alibaba Health Information Technology Limited (HKG:241)?
Apr 16Alibaba Health Information Technology (HKG:241) Might Have The Makings Of A Multi-Bagger
Mar 29Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?
Mar 12With A 25% Price Drop For Alibaba Health Information Technology Limited (HKG:241) You'll Still Get What You Pay For
Jan 17Is Now An Opportune Moment To Examine Alibaba Health Information Technology Limited (HKG:241)?
Jan 07Returns On Capital Are Showing Encouraging Signs At Alibaba Health Information Technology (HKG:241)
Dec 15Shareholders Should Be Pleased With Alibaba Health Information Technology Limited's (HKG:241) Price
Sep 28Alibaba Health Information Technology Limited's (HKG:241) Intrinsic Value Is Potentially 25% Below Its Share Price
Jul 02Is Alibaba Health Information Technology Limited (HKG:241) Potentially Undervalued?
Jun 11Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)
Jun 22Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 49% Undervaluation?
Dec 01Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital
Oct 15Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)
Aug 12Alibaba Health Information Technology (HKG:241) Is Doing The Right Things To Multiply Its Share Price
Jun 25These Analysts Just Made A Huge Downgrade To Their Alibaba Health Information Technology Limited (HKG:241) EPS Forecasts
May 30Earnings Report: Alibaba Health Information Technology Limited Missed Revenue Estimates By 6.8%
May 27The Return Trends At Alibaba Health Information Technology (HKG:241) Look Promising
Mar 23Should You Be Adding Alibaba Health Information Technology (HKG:241) To Your Watchlist Today?
Mar 05How Much Are Alibaba Health Information Technology Limited (HKG:241) Insiders Taking Off The Table?
Feb 15Are Alibaba Health Information Technology's (HKG:241) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 31
If You Had Bought Alibaba Health Information Technology (HKG:241) Stock Three Years Ago, You Could Pocket A 457% Gain Today
Dec 31Has Alibaba Health Information Technology Limited's (HKG:241) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 16Will Alibaba Health Information Technology's (HKG:241) Growth In ROCE Persist?
Dec 01Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | CN¥1b |
| Jun 30 2024 | n/a | n/a | CN¥1b |
| Mar 31 2024 | CN¥7m | CN¥2m | CN¥883m |
| Dec 31 2023 | n/a | n/a | CN¥851m |
| Sep 30 2023 | n/a | n/a | CN¥817m |
| Jun 30 2023 | n/a | n/a | CN¥675m |
| Mar 31 2023 | CN¥6m | CN¥1m | CN¥536m |
| Dec 31 2022 | n/a | n/a | CN¥332m |
| Sep 30 2022 | n/a | n/a | CN¥128m |
| Jun 30 2022 | n/a | n/a | -CN¥69m |
| Mar 31 2022 | CN¥6m | CN¥1m | -CN¥266m |
| Dec 31 2021 | n/a | n/a | -CN¥216m |
| Sep 30 2021 | n/a | n/a | -CN¥167m |
| Jun 30 2021 | n/a | n/a | CN¥91m |
| Mar 31 2021 | n/a | n/a | CN¥349m |
| Dec 31 2020 | n/a | n/a | CN¥313m |
| Sep 30 2020 | n/a | n/a | CN¥278m |
| Jun 30 2020 | n/a | n/a | CN¥136m |
| Mar 31 2020 | CN¥12m | CN¥2m | -CN¥7m |
| Dec 31 2019 | n/a | n/a | -CN¥3m |
| Sep 30 2019 | n/a | n/a | CN¥1m |
| Jun 30 2019 | n/a | n/a | -CN¥40m |
| Mar 31 2019 | CN¥7m | CN¥33k | -CN¥82m |
Vergütung im Vergleich zum Markt: DifanDie Gesamtvergütung ($USD941.64K) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt Hong Kong ($USD868.11K).
Entschädigung vs. Einkommen: DifanDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.
Geschäftsführer
Difan Shen (46 yo)
less than a year
Amtszeit
CN¥6,814,000
Vergütung
Mr. Difan Shen serves as Chief Executive Officer of Alibaba Health Information Technology Limited from November 28, 2023 and serves as Executive Director since October 13, 2021. He was Chief Operating Offi...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Executive Director | less than a year | CN¥6.81m | 0.0089% HK$ 5.2m | |
| CFO & Executive Director | 4.6yrs | CN¥5.34m | 0.0050% HK$ 2.9m | |
| Legal Counsel & Joint Company Secretary | 1.8yrs | keine Daten | keine Daten | |
| Chief Marketing Officer | 2.7yrs | keine Daten | keine Daten | |
| Chief People Officer | 4.8yrs | keine Daten | keine Daten | |
| Financial Controller | no data | keine Daten | keine Daten | |
| Chief Legal Advisor & Joint Company Secretary | 1.3yrs | keine Daten | keine Daten |
2.3yrs
Durchschnittliche Betriebszugehörigkeit
Erfahrenes Management: 241Das Führungsteam des Unternehmens gilt als erfahren (2.3 Jahre durchschnittliche Betriebszugehörigkeit).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Executive Director | 3.1yrs | CN¥6.81m | 0.0089% HK$ 5.2m | |
| CFO & Executive Director | 4.1yrs | CN¥5.34m | 0.0050% HK$ 2.9m | |
| Independent Non-Executive Director | 1.3yrs | CN¥411.00k | keine Daten | |
| Independent Non-Executive Director | 5.4yrs | CN¥348.00k | keine Daten | |
| Non-Executive Chairman of the Board | 4.7yrs | CN¥19.00m | 0.0086% HK$ 5.0m | |
| Independent Non-Executive Director | 1.3yrs | CN¥223.00k | keine Daten | |
| Non-Executive Director | 1.5yrs | keine Daten | keine Daten | |
| Non-Executive Director | 1.1yrs | keine Daten | keine Daten |
2.3yrs
Durchschnittliche Betriebszugehörigkeit
48.5yo
Durchschnittliches Alter
Erfahrener Vorstand: 241Die Vorstandsmitglieder gelten nicht als erfahren ( 2.3 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.